Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Citric Acid | HCID 311 | — |
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | 1-(tert-Butoxycarbonyl)-2-pyrroleboronic Acid | HCID 2734321 | — |
| Reactant | Tert-butyl 4-bromo-2-(5-phenylpyridine-3-carboxamido)benzoate | HCID 58508430 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Catalyst | 2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl | HCID 11269872 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 58508619 | HCID 58508619 | 46.1% |
Reaction Steps
Tripotassium phosphate (0.12 g), 1-(tert-butoxycarbonyl)-1H-pyrrole-2-boronic acid (56 mg), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (1 mg), and palladium(II) acetate (1 mg) were added to a toluene (3.0 mL) solution of tert-butyl 4-bromo-2-(5-phenylpyridine-3-carboxamido)benzoate (0.10 g), followed by heating to reflux under a nitrogen atmosphere for 3 hours. The reaction mixture was cooled to room temperature, and tripotassium phosphate (47 mg), 1-(tert-butoxycarbonyl)-1H-pyrrole-2-boronic acid (47 mg), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (1 mg), and palladium(II) acetate (1 mg) were added thereto, followed by heating to reflux under a nitrogen atmosphere for 1 hour and 30 minutes. The reaction mixture was cooled to room temperature, and ethyl acetate and a 10% aqueous solution of citric acid were added thereto. The organic layer was separated, washed with a saturated aqueous solution of sodium chloride, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. Dioxane (1.5 mL), methanol (1.5 mL), and a 2 mol/L aqueous solution of sodium hydroxide (0.29 mL) were sequentially added to the obtained residue, followed by stiffing at 50° C. for 1 hour and 30 minutes. The reaction mixture was cooled to room temperature, and then a 10% aqueous solution of citric acid and ethyl acetate were sequentially added thereto. The solid substance was collected by filtration to obtain 39 mg of 2-(5-phenylpyridine-3-carboxamido)-4-(1H-pyrrol-2-yl)benzoic acid as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08492582B2 |
|---|
| Source dataset | uspto-grants-2013_07 |
|---|
| ORD ID | ord-810c5e371da54d5982a1ee98dd46dcd5 |
|---|
| Source note | uspto-grants-2013_07 |
|---|